About

Publications While At HealthPartners

selected publications

Journal Article

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial. 

Diabetes care. 2013

Contact

full name

H. Mersebach

Quick Info

 

Collaboration

Co-author network

Map of science